Cargando…

Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease

BACKGROUND: The interaction between immune checkpoint and myeloid-derived suppressor cells (MDSCs) play a significant role in inflammatory diseases. But their correlation with chronic obstructive pulmonary disease (COPD) remains unclear. METHODS: The differentially expressed immune checkpoints and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lijuan, Li, Fengsen, Jiang, Min, Li, Zheng, Xu, Dan, Jing, Jing, Wang, Jing, Ding, Jianbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946009/
https://www.ncbi.nlm.nih.gov/pubmed/36846109
http://dx.doi.org/10.2147/COPD.S394327
_version_ 1784892247180836864
author Xu, Lijuan
Li, Fengsen
Jiang, Min
Li, Zheng
Xu, Dan
Jing, Jing
Wang, Jing
Ding, Jianbing
author_facet Xu, Lijuan
Li, Fengsen
Jiang, Min
Li, Zheng
Xu, Dan
Jing, Jing
Wang, Jing
Ding, Jianbing
author_sort Xu, Lijuan
collection PubMed
description BACKGROUND: The interaction between immune checkpoint and myeloid-derived suppressor cells (MDSCs) play a significant role in inflammatory diseases. But their correlation with chronic obstructive pulmonary disease (COPD) remains unclear. METHODS: The differentially expressed immune checkpoints and immunocytes in the airway tissues of COPD patients were identified by bioinformatics analysis, followed by correlation analysis and identification of immune-related differential genes for Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analysis. The results of bioinformatics analysis were verified by ELISA and Real-Time PCR and transcriptome sequencing of the peripheral blood of both COPD patients and healthy subjects. RESULTS: The results of the bioinformatics analysis showed that the level of MDSCs in airway tissue and peripheral blood of COPD patients was higher than that of healthy controls. The expression of CSF1 in airway tissue and peripheral blood of COPD patients increased, and CYBB was increased in airway tissue and decreased in peripheral blood of COPD patients. The expression of HHLA2 in the airway tissue decreased in COPD patients, and showed a negative correlation with MDSCs, with a correlation coefficient of −0.37. The peripheral blood flow cytometry results indicated that MDSCs and Treg cells of COPD patients were higher than those in the healthy control group. The results of peripheral blood ELISA and RT-PCR showed that the HHLA2 and CSF1 levels in COPD patients were higher than those in the healthy control group. CONCLUSION: In COPD, the bone marrow is stimulated to produce MDSCs, and a large number of MDSCs migrate to airway tissue through peripheral blood and cooperate with HHLA2 to exert an immunosuppressive effect. Whether MDSCs play an immunosuppressive effect during migration needs to be further confirmed.
format Online
Article
Text
id pubmed-9946009
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-99460092023-02-23 Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease Xu, Lijuan Li, Fengsen Jiang, Min Li, Zheng Xu, Dan Jing, Jing Wang, Jing Ding, Jianbing Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: The interaction between immune checkpoint and myeloid-derived suppressor cells (MDSCs) play a significant role in inflammatory diseases. But their correlation with chronic obstructive pulmonary disease (COPD) remains unclear. METHODS: The differentially expressed immune checkpoints and immunocytes in the airway tissues of COPD patients were identified by bioinformatics analysis, followed by correlation analysis and identification of immune-related differential genes for Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analysis. The results of bioinformatics analysis were verified by ELISA and Real-Time PCR and transcriptome sequencing of the peripheral blood of both COPD patients and healthy subjects. RESULTS: The results of the bioinformatics analysis showed that the level of MDSCs in airway tissue and peripheral blood of COPD patients was higher than that of healthy controls. The expression of CSF1 in airway tissue and peripheral blood of COPD patients increased, and CYBB was increased in airway tissue and decreased in peripheral blood of COPD patients. The expression of HHLA2 in the airway tissue decreased in COPD patients, and showed a negative correlation with MDSCs, with a correlation coefficient of −0.37. The peripheral blood flow cytometry results indicated that MDSCs and Treg cells of COPD patients were higher than those in the healthy control group. The results of peripheral blood ELISA and RT-PCR showed that the HHLA2 and CSF1 levels in COPD patients were higher than those in the healthy control group. CONCLUSION: In COPD, the bone marrow is stimulated to produce MDSCs, and a large number of MDSCs migrate to airway tissue through peripheral blood and cooperate with HHLA2 to exert an immunosuppressive effect. Whether MDSCs play an immunosuppressive effect during migration needs to be further confirmed. Dove 2023-02-18 /pmc/articles/PMC9946009/ /pubmed/36846109 http://dx.doi.org/10.2147/COPD.S394327 Text en © 2023 Xu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Xu, Lijuan
Li, Fengsen
Jiang, Min
Li, Zheng
Xu, Dan
Jing, Jing
Wang, Jing
Ding, Jianbing
Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease
title Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease
title_full Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease
title_fullStr Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease
title_full_unstemmed Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease
title_short Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease
title_sort immunosuppression by inflammation-stimulated amplification of myeloid-derived suppressor cells and changes in expression of immune checkpoint hhla2 in chronic obstructive pulmonary disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946009/
https://www.ncbi.nlm.nih.gov/pubmed/36846109
http://dx.doi.org/10.2147/COPD.S394327
work_keys_str_mv AT xulijuan immunosuppressionbyinflammationstimulatedamplificationofmyeloidderivedsuppressorcellsandchangesinexpressionofimmunecheckpointhhla2inchronicobstructivepulmonarydisease
AT lifengsen immunosuppressionbyinflammationstimulatedamplificationofmyeloidderivedsuppressorcellsandchangesinexpressionofimmunecheckpointhhla2inchronicobstructivepulmonarydisease
AT jiangmin immunosuppressionbyinflammationstimulatedamplificationofmyeloidderivedsuppressorcellsandchangesinexpressionofimmunecheckpointhhla2inchronicobstructivepulmonarydisease
AT lizheng immunosuppressionbyinflammationstimulatedamplificationofmyeloidderivedsuppressorcellsandchangesinexpressionofimmunecheckpointhhla2inchronicobstructivepulmonarydisease
AT xudan immunosuppressionbyinflammationstimulatedamplificationofmyeloidderivedsuppressorcellsandchangesinexpressionofimmunecheckpointhhla2inchronicobstructivepulmonarydisease
AT jingjing immunosuppressionbyinflammationstimulatedamplificationofmyeloidderivedsuppressorcellsandchangesinexpressionofimmunecheckpointhhla2inchronicobstructivepulmonarydisease
AT wangjing immunosuppressionbyinflammationstimulatedamplificationofmyeloidderivedsuppressorcellsandchangesinexpressionofimmunecheckpointhhla2inchronicobstructivepulmonarydisease
AT dingjianbing immunosuppressionbyinflammationstimulatedamplificationofmyeloidderivedsuppressorcellsandchangesinexpressionofimmunecheckpointhhla2inchronicobstructivepulmonarydisease